Culture-independent analysis of desulfovibrios in the human distal colon of healthy, colorectal cancer and polypectomized individuals.

The production of hydrogen sulphide, an end product of metabolism by the sulphate-reducing bacteria (SRB) has been cited as a potential aetiological agent in gastrointestinal disease. Quantitative PCR (Q-PCR) assays to enumerate desulfovibrios from two gastrointestinal disease groups: colorectal cancer (CRC) n=27 and polypectomized individuals (PP) n=27, and two healthy control groups, elderly (H1) n=8 and young adults (H2) n=30 was performed. Analysis of Desulfovibrio sp. diversity using the dissimilarity sulphite reductase (dsrAB) gene as a molecular marker was also undertaken. Q-PCR detected Desulfovibrio sp. in all samples and no significant difference was observed for PP, H1, H2 with gene copy numbers of Desulfovibrio sp. averaging at 10(6) g(-1) of faeces. Significantly reduced numbers of Desulfovibrio sp. were observed for CRC (10(5) g(-1)) compared with both PP and H2 groups (P<0.05). Diversity analysis indicated that a low Desulfovibrio sp. diversity and the predominance of Desulfovibrio piger was a feature of both healthy and disease groups. In addition, a dsrAB gene sequence distantly related to a Gram-positive SRB was also recovered, highlighting the importance of cultivation-independent techniques for furthering our understanding of the diversity of the human gastrointestinal ecosystem.

[1]  K. Madsen,et al.  Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[2]  Colin Hill,et al.  Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome , 2008, Proceedings of the National Academy of Sciences.

[3]  Ian D. Wilson,et al.  Metabolic Phenotyping in Health and Disease , 2008, Cell.

[4]  A. Stams,et al.  The ecology and biotechnology of sulphate-reducing bacteria , 2008, Nature Reviews Microbiology.

[5]  Haifeng Lu,et al.  Symbiotic gut microbes modulate human metabolic phenotypes , 2008, Proceedings of the National Academy of Sciences.

[6]  W. Weichert,et al.  Fungi and inflammatory bowel diseases: Alterations of composition and diversity , 2008, Scandinavian journal of gastroenterology.

[7]  M. Gilmore,et al.  The commensal microbiology of the gastrointestinal tract. , 2008, Advances in experimental medicine and biology.

[8]  F. Shanahan,et al.  Human methanogen diversity and incidence in healthy and diseased colonic groups using mcrA gene analysis , 2008, BMC Microbiology.

[9]  I. Pereira,et al.  Hydrogen as an energy source for the human pathogen Bilophila wadsworthia , 2008, Antonie van Leeuwenhoek.

[10]  Y. Maeda,et al.  Hydrogen sulfide as a novel nociceptive messenger , 2007, Pain.

[11]  G. Macfarlane,et al.  Mucosa-Associated Bacterial Diversity in Relation to Human Terminal Ileum and Colonic Biopsy Samples , 2007, Applied and Environmental Microbiology.

[12]  N. Pace,et al.  Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases , 2007, Proceedings of the National Academy of Sciences.

[13]  M. Nei,et al.  MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. , 2007, Molecular biology and evolution.

[14]  R. Wilson,et al.  Genomic and metabolic adaptations of Methanobrevibacter smithii to the human gut , 2007, Proceedings of the National Academy of Sciences.

[15]  F. Hauck,et al.  Sudden infant death syndrome , 2007, The Lancet.

[16]  M. Attene-Ramos,et al.  Hydrogen Sulfide Induces Direct Radical-Associated DNA Damage , 2007, Molecular Cancer Research.

[17]  M. Washington,et al.  Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. , 2007, Gastroenterology.

[18]  H. Takeyama,et al.  [Bilophila wadsworthia isolated from surgical specimens]. , 2006, The Japanese journal of antibiotics.

[19]  Gerard Muyzer,et al.  Analysis of Diversity and Activity of Sulfate-Reducing Bacterial Communities in Sulfidogenic Bioreactors Using 16S rRNA and dsrB Genes as Molecular Markers , 2006, Applied and Environmental Microbiology.

[20]  J. Wallace,et al.  Hydrogen sulfide is an endogenous modulator of leukocyte‐mediated inflammation , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  F. Shanahan,et al.  Culture-Independent Analyses of Temporal Variation of the Dominant Fecal Microbiota and Targeted Bacterial Subgroups in Crohn's Disease , 2006, Journal of Clinical Microbiology.

[22]  P. Tanière,et al.  Sulfide-detoxifying enzymes in the human colon are decreased in cancer and upregulated in differentiation. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[23]  A. Murray,et al.  Carriage, quantification, and predominance of methanogens and sulfate‐reducing bacteria in faecal samples , 2006, Letters in applied microbiology.

[24]  J. Wallace,et al.  The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. , 2006, Gastroenterology.

[25]  M. Attene-Ramos,et al.  Evidence That Hydrogen Sulfide Is a Genotoxic Agent , 2006, Molecular Cancer Research.

[26]  L. Rossaro,et al.  Sudden infant death syndrome: the colon connection. , 2006, Medical hypotheses.

[27]  E. Goldstein,et al.  Biochemical Differentiation and Comparison of Desulfovibrio Species and Other Phenotypically Similar Genera , 2005, Journal of Clinical Microbiology.

[28]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[29]  L. Ferguson,et al.  Dietary fibres as "prebiotics": implications for colorectal cancer. , 2005, Molecular nutrition & food research.

[30]  M. Wagner,et al.  Lateral Gene Transfer of Dissimilatory (Bi)Sulfite Reductase Revisited , 2005, Journal of bacteriology.

[31]  D. Rothenberger,et al.  Association Between Fecal Hydrogen Sulfide Production and Pouchitis , 2005, Diseases of the colon and rectum.

[32]  T. Ørntoft,et al.  Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid , 2005, Gut.

[33]  A. Palva,et al.  Analysis of the Fecal Microbiota of Irritable Bowel Syndrome Patients and Healthy Controls with Real-Time PCR , 2005, The American Journal of Gastroenterology.

[34]  M. Wagner,et al.  Microarray and Functional Gene Analyses of Sulfate-Reducing Prokaryotes in Low-Sulfate, Acidic Fens Reveal Cooccurrence of Recognized Genera and Novel Lineages , 2004, Applied and Environmental Microbiology.

[35]  H. Gaskins,et al.  Commensal Bacteria, Redox Stress, and Colorectal Cancer: Mechanisms and Models , 2004, Experimental biology and medicine.

[36]  G. Macfarlane,et al.  Identification and quantitation of mucosal and faecal desulfovibrios using real time polymerase chain reaction , 2004, Gut.

[37]  J. Gordon,et al.  Honor thy symbionts , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[38]  V. Peraino,et al.  Desulfovibrio desulfuricans Bacteremia and Review of Human Desulfovibrio Infections , 2003, Journal of Clinical Microbiology.

[39]  T. Ørntoft,et al.  Gene expression in colorectal cancer. , 2002, Cancer research.

[40]  P. Grimont,et al.  Reclassification of the only species of the genus Desulfomonas, Desulfomonas pigra, as Desulfovibrio piger comb. nov. , 2002, International journal of systematic and evolutionary microbiology.

[41]  I. Pereira,et al.  Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases. , 2002, FEMS microbiology ecology.

[42]  M. Langman,et al.  Mucosal protection against sulphide: importance of the enzyme rhodanese , 2002, Gut.

[43]  M. Langman,et al.  Sulphide‐induced energy deficiency in colonic cells is prevented by glucose but not by butyrate , 2002, Alimentary pharmacology & therapeutics.

[44]  P. Langendijk-Genevaux,et al.  Sulfate-reducing bacteria in relation with other potential periodontal pathogens. , 2001, Journal of clinical periodontology.

[45]  A. Bird,et al.  Colonic Infection by Bilophila wadsworthia in Pigs , 2001, Journal of Clinical Microbiology.

[46]  J. S. van der Hoeven,et al.  Sulfate-reducing bacteria in association with human periodontitis. , 2000, Journal of clinical periodontology.

[47]  I. Beech,et al.  Screening of sulfate-reducing bacteria in colonoscopy samples from healthy and colitic human gut mucosa. , 2000, FEMS microbiology ecology.

[48]  J. Doré,et al.  Quantification of Bacterial Groups within Human Fecal Flora by Oligonucleotide Probe Hybridization , 2000, Applied and Environmental Microbiology.

[49]  A. L. Le Faou,et al.  Bacteremia Caused by a Strain of Desulfovibrio Related to the Provisionally Named Desulfovibrio fairfieldensis , 2000, Journal of Clinical Microbiology.

[50]  S. Bingham,et al.  Diet and the prevention of cancer , 1998, BMJ.

[51]  Michael Wagner,et al.  Phylogeny of Dissimilatory Sulfite Reductases Supports an Early Origin of Sulfate Respiration , 1998, Journal of bacteriology.

[52]  J. Furne,et al.  Fecal Hydrogen Sulfide Production in Ulcerative Colitis , 1998, American Journal of Gastroenterology.

[53]  J. Thompson,et al.  The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. , 1997, Nucleic acids research.

[54]  Bacteremia caused by a recently described novel Desulfovibrio species , 1997, Journal of clinical microbiology.

[55]  H. Laue,et al.  Taurine reduction in anaerobic respiration of Bilophila wadsworthia RZATAU , 1997, Applied and environmental microbiology.

[56]  F. Häcker,et al.  Incidence of Bilophila wadsworthia in appendiceal, peritoneal and fecal samples from children. , 1997, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[57]  J. Cummings,et al.  Hydrogen sulphide: a bacterial toxin in ulcerative colitis? , 1996, Gut.

[58]  K. Kanazawa,et al.  Factors influencing the development of sigmoid colon cancer: Bacteriologic and biochemical studies , 1996, Cancer.

[59]  K. Wilson,et al.  Preliminary study using species-specific oligonucleotide probe for rRNA of Bilophila wadsworthia , 1994, Journal of clinical microbiology.

[60]  G. Macfarlane,et al.  Sulphate reducing bacteria and hydrogen metabolism in the human large intestine. , 1993, Gut.

[61]  W. Roediger,et al.  Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. , 1993, Gastroenterology.

[62]  E. Baron,et al.  Bilophila wadsworthia isolates from clinical specimens. , 1995, Journal of clinical microbiology.

[63]  G. Macfarlane,et al.  Growth and activities of sulphate-reducing bacteria in gut contents of healthy subjects and patients with ulcerative colitis , 1991 .

[64]  D. Lane.  16S/23S rRNA sequencing , 1991 .

[65]  E. Stackebrandt,et al.  Nucleic acid techniques in bacterial systematics , 1991 .

[66]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[67]  D. Stahl,et al.  Diversity and origin of Desulfovibrio species: phylogenetic definition of a family , 1990, Journal of bacteriology.

[68]  N. Saitou,et al.  The neighbor-joining method: a new method for reconstructing phylogenetic trees. , 1987, Molecular biology and evolution.

[69]  C. Romond,et al.  Sulfate-reducing anaerobic bacteria in human feces. , 1977, The American journal of clinical nutrition.